Literature DB >> 30894413

Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

Julie M Leth1,2, Haydyn D T Mertens3, Katrine Zinck Leth-Espensen1,2,4, Thomas J D Jørgensen4, Michael Ploug5,2.   

Abstract

The urokinase receptor (uPAR) is a founding member of a small protein family with multiple Ly6/uPAR (LU) domains. The motif defining these LU domains contains five plesiotypic disulfide bonds stabilizing its prototypical three-fingered fold having three protruding loops. Notwithstanding the detailed knowledge on structure-function relationships in uPAR, one puzzling enigma remains unexplored. Why does the first LU domain in uPAR (DI) lack one of its consensus disulfide bonds, when the absence of this particular disulfide bond impairs the correct folding of other single LU domain-containing proteins? Here, using a variety of contemporary biophysical methods, we found that reintroducing the two missing half-cystines in uPAR DI caused the spontaneous formation of the corresponding consensus 7-8 LU domain disulfide bond. Importantly, constraints due to this cross-link impaired (i) the binding of uPAR to its primary ligand urokinase and (ii) the flexible interdomain assembly of the three LU domains in uPAR. We conclude that the evolutionary deletion of this particular disulfide bond in uPAR DI may have enabled the assembly of a high-affinity urokinase-binding cavity involving all three LU domains in uPAR. Of note, an analogous neofunctionalization occurred in snake venom α-neurotoxins upon loss of another pair of the plesiotypic LU domain half-cystines. In summary, elimination of the 7-8 consensus disulfide bond in the first LU domain of uPAR did have significant functional and structural consequences.
© 2019 Leth et al.

Entities:  

Keywords:  LU domain; disulfide; fibrinolysis; hydrogen exchange mass spectrometry; plasminogen regulation; protein evolution; receptor structure-function; small-angle X-ray scattering (SAXS); surface plasmon resonance (SPR); urokinase receptor

Mesh:

Substances:

Year:  2019        PMID: 30894413      PMCID: PMC6509485          DOI: 10.1074/jbc.RA119.007847

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Plasminogen activator promotes recovery following spinal cord injury.

Authors:  Nicholas Seeds; Steve Mikesell; Rebekah Vest; Thomas Bugge; Kristin Schaller; Kenneth Minor
Journal:  Cell Mol Neurobiol       Date:  2011-05-14       Impact factor: 5.046

2.  Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.

Authors:  Paola Merino; Ariel Diaz; Valerie Jeanneret; Fang Wu; Enrique Torre; Lihong Cheng; Manuel Yepes
Journal:  J Biol Chem       Date:  2016-12-16       Impact factor: 5.157

3.  Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide.

Authors:  Paola Llinas; Marie Hélène Le Du; Henrik Gårdsvoll; Keld Danø; Michael Ploug; Bernard Gilquin; Enrico A Stura; André Ménez
Journal:  EMBO J       Date:  2005-04-07       Impact factor: 11.598

4.  Re-engineering the Immune Response to Metastatic Cancer: Antibody-Recruiting Small Molecules Targeting the Urokinase Receptor.

Authors:  Anthony F Rullo; Kelly J Fitzgerald; Viswanathan Muthusamy; Min Liu; Cai Yuan; Mingdong Huang; Minsup Kim; Art E Cho; David A Spiegel
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-16       Impact factor: 15.336

5.  GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.

Authors:  Anne P Beigneux; Loren G Fong; André Bensadoun; Brandon S J Davies; Monika Oberer; Henrik Gårdsvoll; Michael Ploug; Stephen G Young
Journal:  Circ Res       Date:  2014-11-11       Impact factor: 17.367

6.  A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.

Authors:  Ariel Diaz; Paola Merino; Luis Guillermo Manrique; Juan Pablo Ospina; Lihong Cheng; Fang Wu; Valerie Jeanneret; Manuel Yepes
Journal:  J Neurosci       Date:  2017-09-20       Impact factor: 6.167

7.  Predicting disulfide bond connectivity in proteins by correlated mutations analysis.

Authors:  Rotem Rubinstein; Andras Fiser
Journal:  Bioinformatics       Date:  2008-01-18       Impact factor: 6.937

8.  Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins.

Authors:  M Ploug; M Kjalke; E Rønne; U Weidle; G Høyer-Hansen; K Danø
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

9.  First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Authors:  Morten Persson; Dorthe Skovgaard; Malene Brandt-Larsen; Camilla Christensen; Jacob Madsen; Carsten H Nielsen; Tine Thurison; Thomas Levin Klausen; Søren Holm; Annika Loft; Anne Kiil Berthelsen; Michael Ploug; Helle Pappot; Klaus Brasso; Niels Kroman; Liselotte Højgaard; Andreas Kjaer
Journal:  Theranostics       Date:  2015-09-13       Impact factor: 11.556

10.  Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering.

Authors:  Giancarlo Tria; Haydyn D T Mertens; Michael Kachala; Dmitri I Svergun
Journal:  IUCrJ       Date:  2015-02-26       Impact factor: 4.769

View more
  5 in total

1.  The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding.

Authors:  Katrine Z Leth-Espensen; Kristian K Kristensen; Anni Kumari; Anne-Marie L Winther; Stephen G Young; Thomas J D Jørgensen; Michael Ploug
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

2.  Unfolding of monomeric lipoprotein lipase by ANGPTL4: Insight into the regulation of plasma triglyceride metabolism.

Authors:  Kristian K Kristensen; Katrine Zinck Leth-Espensen; Haydyn D T Mertens; Gabriel Birrane; Muthuraman Meiyappan; Gunilla Olivecrona; Thomas J D Jørgensen; Stephen G Young; Michael Ploug
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-07       Impact factor: 11.205

Review 3.  Evolution and Medical Significance of LU Domain-Containing Proteins.

Authors:  Julie Maja Leth; Katrine Zinck Leth-Espensen; Kristian Kølby Kristensen; Anni Kumari; Anne-Marie Lund Winther; Stephen G Young; Michael Ploug
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

4.  Crystal structure and cellular functions of uPAR dimer.

Authors:  Shujuan Yu; Yaqun Sui; Jiawei Wang; Yongdong Li; Hanlin Li; Yingping Cao; Liqing Chen; Longguang Jiang; Cai Yuan; Mingdong Huang
Journal:  Nat Commun       Date:  2022-03-29       Impact factor: 14.919

Review 5.  GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL Activity.

Authors:  Kristian Kølby Kristensen; Katrine Zinck Leth-Espensen; Anni Kumari; Anne Louise Grønnemose; Anne-Marie Lund-Winther; Stephen G Young; Michael Ploug
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.